|
BALTIMORE, MD—December 5, 2013—Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), is pleased to announce the availability of its latest CME/CE offering for anesthesia providers, Strategies for Optimal Intraoperative Use of Opioid Agents.
Because of their rapid onset and time to peak effectiveness, short-acting opioids are the most commonly used analgesics in anesthetic regimens. This CME/CE-certified series explores considerations for balancing the efficacy, safety, and cost of these analgesic agents to optimize anesthetic outcomes. It includes six interactive Webcasts and one online publication.
“In order to plan safe and effective opioid-based anesthetic regimens and avoid opioid-related adverse events, we must thoroughly assess both patient- and drug-related factors,” said Peter S.A. Glass, MB, ChB, Professor Emeritus from the Department of Anesthesiology at Stony Brook Medicine. “This online CME/CE series offers anesthesia providers a comprehensive review of the benefits, risks, and pharmacokinetic and pharmacodynamic properties of short-acting opioids to assist in selecting appropriate analgesic agents for intraoperative use.”
Online CME/CE-Certified Publication:
CME-Certified Webcasts:
FACULTY
 |
|
Peter S.A. Glass, MB, ChB
Professor Emeritus
Department of Anesthesiology
Stony Brook Medicine
Stony Brook, NY
|
| |
|
|
 |
|
Mark Antoszyk, CRNA
Director of Nurse Anesthesia
Carolinas Healthcare System
Carolinas Medical Center—Northeast
Concord, NC
|
The publication is approved for AMA PRA Category 1 Credit™, as well as contact hours for nurses and pharmacists. The Webcasts are approved for AMA PRA Category 1 Credit™. This series is supported by an educational grant from Mylan Specialty L.P. The views represented in this CME/CE series are the personal opinions of Dr. Glass and not the opinions of Stony Brook University.
For more information, visit www.Med-IQ.com/s49, call (toll-free) 866 858 7434, or e-mail info@med-iq.com.
|
|
About Med-IQ
Med-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.
Med-IQ, a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives, has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award 2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.
For more information, contact:
|
